Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), receives Breakthrough Therapy Designation and ...

As of December 31, 2024, the Company had cash and cash equivalents in the amount of $15.6 million, compared to $5.3 million ...

Alto Neuroscience, Inc. ("Alto") , a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced a favorable ...

Q3 2025 Earnings Call Transcript February 11, 2025 Jerash Holdings (US), Inc. beats earnings expectations. Reported EPS is ...

Plan map showing Greens Creek ore bodies and fourth quarter 2024 underground exploration and definition drilling targeting ...

Speaking as a medical consultant, I would like to support comments about poor detection by doctors of abuse or coercion of the elderly being considered for assisted dying (“Keep role for judges in ...

BorgWarner has been awarded on the Forbes list of America's Best Employers 2025 for the sixth time. This prestigious award is presented in collaboration with Statista, the world-leading statistics ...

Perhaps you've heard that pitchers and catchers are reporting this week, and perhaps you've taken that as your cue to tune ...

Annual Regulatory Oversight Report provides member firms with key insights and observations from its regulatory operations programs. The report covers fixtures such as financial crimes prevention, ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

How do we stable the bolted horses? …In the first part of this series, we set the context for this paper, highlighting the dividends our forebears expected our democracy to yield and the broad ...